Extractive colorimetric method development and validation for erlotinib in bulk and tablet dosage form
作者： G Usha Rani , B Chandrasekhar , N Devanna , None
DOI:
关键词:
摘要: … Bromocresol Green (BCG) and Methyl Orange (MO) in phosphate buffer pH 2.5, and extracted in chloroform. This property of the drug was followed for the development of colorimetric …
参考文章(4)
José Baselga, Lisa A. Hammond, HER-Targeted Tyrosine-Kinase Inhibitors Oncology. ,vol. 63, pp. 6- 16 ,(2002) , 10.1159/000066198
Ann Birner, Pharmacology of oral chemotherapy agents. Clinical Journal of Oncology Nursing. ,vol. 7, pp. 11- 19 ,(2003) , 10.1188/03.CJON.S6.11-19
M HIDALGO, D BLOEDOW, Pharmacokinetics and pharmacodynamics: Maximizing the clinical potential of Erlotinib (Tarceva) Seminars in Oncology. ,vol. 30, pp. 25- 33 ,(2003) , 10.1016/S0093-7754(03)70012-8
Frances A. Shepherd, José Rodrigues Pereira, Tudor Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert, Daniel Campos, Savitree Maoleekoonpiroj, Michael Smylie, Renato Martins, Maximiliano van Kooten, Mircea Dediu, Brian Findlay, Dongsheng Tu, Dianne Johnston, Andrea Bezjak, Gary Clark, Pedro Santabárbara, Lesley Seymour, Erlotinib in previously treated non-small-cell lung cancer. The New England Journal of Medicine. ,vol. 353, pp. 123- 132 ,(2005) , 10.1056/NEJMOA050753